NCT07031479View on ClinicalTrials.gov

Efficacy of Itopride Versus Metoclopramide in Hospitalized Medicine Patients With High Gastric Residual Volume

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

September 30, 2026

Conditions
Feeding Intolerance
Interventions
DRUG

Itopride HCI 50 mg

Enteral Itopride 50 mg enterally tid ac

DRUG

Metoclopramide 10 mg ampoule

"Intravenous Metoclopramide (10 mg IV q 6 hours)~CrCl 15-60 ml/min: Metoclopramide 5 mg IV q 6 hours CrCl \<15 ml/min: Metoclopramide 5 mg IV q 12 hours Hepatic impairment/ cirrhosis: Metoclopramide 5 mg IV q 6 hours"

All Listed Sponsors
lead

Chulalongkorn University

OTHER